OR WAIT null SECS
March 09, 2022
Spectrum Chemical has further expanded its bioCERTIFIED product portfolio to support the growing global demand for new vaccines and therapeutics.
March 08, 2022
Amgen has announced the groundbreaking of its newest biomanufacturing facility in North Carolina.
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.
G-CON’s signature standardPOD cleanrooms will now be available in Europe.
Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
What if we are underestimating China’s response to US/EU inshoring?
March 07, 2022
Researchers at McGill University have made advancements with a novel method for growing synthetic bone tissue.
Bio-Rad has launched a range of antibodies specifically for daratumumab that inhibit the binding of the drug to the target antigen, CD38, which allows for highly specific bioanalysis and drug monitoring.
March 04, 2022
FDA’s CDER continues to make rare diseases a priority with drug approvals and programming to speed therapeutic development.